2.0
15 June 2026
Former employee
Perth, Western Australia
Recommend
CEO approval
Business outlook
Pros
Previously had expert CSO for informative drug design.
Cons
Toxic positivity, unrealistic milestones that constantly set the company in a rhythym of racing 3 steps forward and 5 steps back. Chronic burnout experienced by benchside scientists, which contributed to the high turnover and subsequent brain-drain.